Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Modified total Sharp scoreMissing dataOutlierPrognostic factorsRadiographic progressionRheumatoid arthritisTofacitinibSensitivity analyses
